The forecasted data indicates a consistent decline in the total number of 10% top-cited scientific publications in drug discovery in the US from 2024 to 2028, with a Compound Annual Growth Rate (CAGR) showing a negative trend. The predicted year-on-year drop is more than 2% annually. In 2023, these publications were slightly higher than in 2024, but it's important to note this downward trajectory through to 2028, with the number decreasing steadily each year.

Future trends to watch for:

Impact of emerging AI and machine learning technologies to boost research capabilities and possibly invigorate publication quality and citation rankings.
Potential shifts in funding and policy that could affect research outputs in drug discovery.
Increasing collaborations in global research efforts that might alter US contribution dynamics in eminent scientific publications.